Snoring too much? Philips, Guardian offer sleep apnea screening

Snoring too much? Philips, Guardian offer sleep apnea screening
The Philips RUSleeping kiosk. Photo: Philips, Guardian
Philips teams up with Guardian to offer screenings for Obstructive Sleep Apnea, which may lead to diabetes and heart disease
Published: 11:07 AM, August 22, 2013
Updated: 4:00 AM, August 23, 2013
(Page 1 of 2) - NEXT PAGE | SINGLE PAGE

SINGAPORE — Electronics and healthcare company Philips said today (Aug 22) that it is working with Guardian pharmacies to offer free sleep apnea screenings in Singapore.

Snoring is one of the key signs of Obstructive Sleep Apnea (OSA), the most common sleep disorder characterised by an airway collapse behind the tongue during sleep, which obstructs breathing. Left untreated, OSA may lead to serious chronic diseases including diabetes, heart attacks and strokes.

To help OSA sufferers identify and treat this disorder, Philips will be offering free screenings at five Guardian outlets from Aug 5. The screenings will end on Nov 5, when Philips will review whether it will continue offering the free screenings.

The Philips RUSleeping kiosks are at Guardian pharmacies in Jurong Point, Paragon, Causeway Point, Nex and Ion Orchard.

Guardian patrons can visit the kiosks for educational material on OSA to help determine if they have symptoms of the disorder. Those who wish to be screened for OSA will then have to complete a sleep evaluation survey to identify if they are at risk.

Upon completing the questionnaire, a Guardian pharmacist will issue a RUSleeping Real-Time Screener (RTS) home sleep diagnostic device, with the patient paying a S$30 deposit fee which will be refunded when the RTS is returned. There will be a S$10 charge for the consultation and S$9 for a cannula.

The RTS device will track users’ sleep for nine hours and collect data that may indicate sleep apnea. The device, which assigns a unique serial number to each user, will record sleep data in real time and provide evidence of potential periods of breath interruption, which could indicate sleep apnea.

If the RTS shows evidence of potential OSA, the Guardian pharmacist will provide patient-care counselling on treatment options — if the patient decides to follow up with a specialist at a hospital, for instance.


(Page 1 of 2) - NEXT PAGE | SINGLE PAGE


  • 1
  • 2